Home > Publications database > Factors Associated With Employment and Quality of Working Life in Patients With Metastatic Breast Cancer. > print

001     303216
005     20250730114249.0
024 7 _ |a 10.1002/cam4.71074
|2 doi
024 7 _ |a pmid:40714912
|2 pmid
024 7 _ |a pmc:PMC12296696
|2 pmc
037 _ _ |a DKFZ-2025-01567
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Kias, Alina
|0 P:(DE-He78)0b9996b44eae403b7cbb0fce2793e3c6
|b 0
|e First author
|u dkfz
245 _ _ |a Factors Associated With Employment and Quality of Working Life in Patients With Metastatic Breast Cancer.
260 _ _ |a Hoboken, NJ
|c 2025
|b Wiley
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1753794901_3434
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
500 _ _ |a #EA:C110#LA:C110#
520 _ _ |a As survival of patients with metastatic breast cancer (MBC) improves, their work situation is gaining importance. The aim of the current study was to identify factors associated with work status and quality of working life (QWL) in patients with MBC. Additionally, we investigated the effects of an exercise intervention on work status.Within the multinational PREFERABLE-EFFECT exercise trial, 287 patients with MBC of working age (18-65 years) reported on their working situation over 9 months as a secondary endpoint. Among a subgroup of participants, QWL was assessed by the Quality of Working Life Questionnaire for Cancer Survivors (QWLQ-CS) (N = 59).At baseline, 157 (54.7%) participants were employed, of whom one-third reported having recently reduced their amount of work because of fatigue (41.7%), cognitive problems (33.3%), or inability to meet work demands (33.3%). Participants wished for more flexible working hours (29.2%) and less productivity pressure (37.5%). Participants were less likely to work if they experienced higher levels of pain (p = 0.014). Among working participants, an academic education and higher levels of psychological distress were associated with a higher number of working hours (all p < 0.05). Fatigue, an academic education, and performing mentally strenuous tasks at work were negatively associated with QWL (all p < 0.05). The exercise intervention did not affect the number of hours worked during the study.Symptom management might be important for patients' ability to work. To help patients stay employed and improve QWL, employers should consider offering more flexible work arrangements and adapting to their employees' changing needs and abilities.The PREFERABLE-EFFECT trial was registered with ClinicalTrials.gov on October 9, 2019 (NCT04120298).
536 _ _ |a 313 - Krebsrisikofaktoren und Prävention (POF4-313)
|0 G:(DE-HGF)POF4-313
|c POF4-313
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
650 _ 7 |a employment
|2 Other
650 _ 7 |a exercise
|2 Other
650 _ 7 |a fatigue
|2 Other
650 _ 7 |a metastatic breast cancer
|2 Other
650 _ 7 |a pain
|2 Other
650 _ 7 |a quality of working life
|2 Other
700 1 _ |a Schmidt, Martina
|0 P:(DE-He78)2def8f8594c8f797f5ed4398258c6cac
|b 1
|u dkfz
700 1 _ |a Hiensch, Anouk E
|0 0000-0002-6216-2609
|b 2
700 1 _ |a Clauss, Dorothea
|0 P:(DE-He78)f52b77d7ab843c9b900134aafc61638a
|b 3
|u dkfz
700 1 _ |a Monninkhof, Evelyn M
|b 4
700 1 _ |a Pelaez, Mireia
|0 0000-0001-8022-4925
|b 5
700 1 _ |a Belloso, Jon
|b 6
700 1 _ |a Gunasekara, Nadira
|0 0009-0008-5847-7086
|b 7
700 1 _ |a Sweegers, Maike G
|0 0000-0003-4892-4061
|b 8
700 1 _ |a Trevaskis, Mark
|0 0000-0002-9078-0180
|b 9
700 1 _ |a Rundqvist, Helene
|0 0000-0002-5617-9076
|b 10
700 1 _ |a Müller, Jana
|b 11
700 1 _ |a Wiskemann, Joachim
|b 12
700 1 _ |a van der Wall, Elsken
|b 13
700 1 _ |a Aaronson, Neil K
|b 14
700 1 _ |a Lachowicz, Milena
|0 0000-0002-8402-0564
|b 15
700 1 _ |a Urruticoechea, Ander
|0 0000-0003-0359-3641
|b 16
700 1 _ |a Zopf, Eva M
|0 0000-0001-6250-0041
|b 17
700 1 _ |a Bloch, Wilhelm
|b 18
700 1 _ |a Stuiver, Martijn M
|0 0000-0002-7794-7767
|b 19
700 1 _ |a Wengström, Yvonne
|0 0000-0001-8317-7829
|b 20
700 1 _ |a May, Anne M
|0 0000-0003-0643-3790
|b 21
700 1 _ |a Steindorf, Karen
|0 P:(DE-He78)a0c2037d9054be26907a05ae520d5756
|b 22
|e Last author
|u dkfz
773 _ _ |a 10.1002/cam4.71074
|g Vol. 14, no. 15, p. e71074
|0 PERI:(DE-600)2659751-2
|n 15
|p e71074
|t Cancer medicine
|v 14
|y 2025
|x 2045-7634
909 C O |o oai:inrepo02.dkfz.de:303216
|p VDB
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 0
|6 P:(DE-He78)0b9996b44eae403b7cbb0fce2793e3c6
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 1
|6 P:(DE-He78)2def8f8594c8f797f5ed4398258c6cac
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 3
|6 P:(DE-He78)f52b77d7ab843c9b900134aafc61638a
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 22
|6 P:(DE-He78)a0c2037d9054be26907a05ae520d5756
913 1 _ |a DE-HGF
|b Gesundheit
|l Krebsforschung
|1 G:(DE-HGF)POF4-310
|0 G:(DE-HGF)POF4-313
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Krebsrisikofaktoren und Prävention
|x 0
914 1 _ |y 2025
915 _ _ |a DEAL Wiley
|0 StatID:(DE-HGF)3001
|2 StatID
|d 2025-01-07
|w ger
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b CANCER MED-US : 2022
|d 2025-01-07
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2025-01-07
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2025-01-07
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0501
|2 StatID
|b DOAJ Seal
|d 2024-08-08T17:04:21Z
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0500
|2 StatID
|b DOAJ
|d 2024-08-08T17:04:21Z
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b DOAJ : Anonymous peer review
|d 2024-08-08T17:04:21Z
915 _ _ |a Creative Commons Attribution CC BY (No Version)
|0 LIC:(DE-HGF)CCBYNV
|2 V:(DE-HGF)
|b DOAJ
|d 2024-08-08T17:04:21Z
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
|d 2025-01-07
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
|d 2025-01-07
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2025-01-07
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2025-01-07
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2025-01-07
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1190
|2 StatID
|b Biological Abstracts
|d 2025-01-07
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1110
|2 StatID
|b Current Contents - Clinical Medicine
|d 2025-01-07
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2025-01-07
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2025-01-07
915 _ _ |a IF < 5
|0 StatID:(DE-HGF)9900
|2 StatID
|d 2025-01-07
915 _ _ |a Article Processing Charges
|0 StatID:(DE-HGF)0561
|2 StatID
|d 2025-01-07
915 _ _ |a Fees
|0 StatID:(DE-HGF)0700
|2 StatID
|d 2025-01-07
920 2 _ |0 I:(DE-He78)C110-20160331
|k C110
|l Bewegung, Krebsprävention und Survivorship
|x 0
920 1 _ |0 I:(DE-He78)C110-20160331
|k C110
|l Bewegung, Krebsprävention und Survivorship
|x 0
920 0 _ |0 I:(DE-He78)C110-20160331
|k C110
|l Bewegung, Krebsprävention und Survivorship
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)C110-20160331
980 _ _ |a UNRESTRICTED

LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21